Clinical Trial Details
| Trial ID: | L4985 |
| Source ID: | NCT00320502 |
| Associated Drug: | Bxt-51072 |
| Title: | A Phase 2 Study to Determine the Effects of BXT-51072 in Diabetic Patients Undergoing Angioplasty (PCI) |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Acute Coronary Syndrome|Type 2 Diabetes |
| Interventions: | DRUG: BXT-51072 |
| Outcome Measures: | Primary: Change in CK-MB|Safety | Secondary: Change in troponin|Myocardial ischemia by 24-hour continuous 12-lead ECG |
| Sponsor/Collaborators: | Sponsor: Synvista Therapeutics, Inc |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE2 |
| Enrollment: | 60 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT |
| Start Date: | 2006-05 |
| Completion Date: | 2008-08 |
| Results First Posted: | |
| Last Update Posted: | 2008-08-25 |
| Locations: | Rambam Medical Center, Haifa, 31096, Israel|Western Galilee Hospital, Nahariya, 22100, Israel|Rivka Sieff Hospital, Safed, 13100, Israel|Sourasky Medical Center, Tel Aviv, 64239, Israel |
| URL: | https://clinicaltrials.gov/show/NCT00320502 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|